The antitumor activity of plant-derived non-psychoactive cannabinoids
SD McAllister, L Soroceanu, PY Desprez - Journal of neuroimmune …, 2015 - Springer
As a therapeutic agent, most people are familiar with the palliative effects of the primary
psychoactive constituent of Cannabis sativa (CS), Δ 9-tetrahydrocannabinol (THC), a …
psychoactive constituent of Cannabis sativa (CS), Δ 9-tetrahydrocannabinol (THC), a …
A review of the therapeutic antitumor potential of cannabinoids
V Bogdanović, J Mrdjanović, I Borišev - The Journal of Alternative …, 2017 - liebertpub.com
Objectives: The aim of this review is to discuss cannabinoids from a preclinical and clinical
oncological perspective and provide the audience with a concise, retrospective overview of …
oncological perspective and provide the audience with a concise, retrospective overview of …
[HTML][HTML] Cannabinoids as anticancer drugs: current status of preclinical research
B Hinz, R Ramer - British journal of cancer, 2022 - nature.com
Drugs that target the endocannabinoid system are of interest as pharmacological options to
combat cancer and to improve the life quality of cancer patients. From this perspective …
combat cancer and to improve the life quality of cancer patients. From this perspective …
Cannabinoids for cancer treatment: progress and promise
Cannabinoids are a class of pharmacologic compounds that offer potential applications as
antitumor drugs, based on the ability of some members of this class to limit inflammation, cell …
antitumor drugs, based on the ability of some members of this class to limit inflammation, cell …
Control of the cell survival/death decision by cannabinoids
M Guzmán, C Sánchez, I Galve-Roperh - Journal of molecular medicine, 2001 - Springer
Cannabinoids, the active components of Cannabis sativa (marijuana), and their derivatives
produce a wide spectrum of central and peripheral effects, some of which may have clinical …
produce a wide spectrum of central and peripheral effects, some of which may have clinical …
Antitumorigenic effects of cannabinoids beyond apoptosis
N Freimuth, R Ramer, B Hinz - Journal of Pharmacology and Experimental …, 2010 - ASPET
According to the World Health Organization, the cases of death caused by cancer will have
been doubled until the year 2030. By 2010, cancer is expected to be the number one cause …
been doubled until the year 2030. By 2010, cancer is expected to be the number one cause …
[HTML][HTML] Anticancer mechanisms of cannabinoids
In addition to the well-known palliative effects of cannabinoids on some cancer-associated
symptoms, a large body of evidence shows that these molecules can decrease tumour …
symptoms, a large body of evidence shows that these molecules can decrease tumour …
Critical appraisal of the potential use of cannabinoids in cancer management
BJ Cridge, RJ Rosengren - Cancer management and research, 2013 - Taylor & Francis
Cannabinoids have been attracting a great deal of interest as potential anticancer agents.
Originally derived from the plant Cannabis sativa, there are now a number of endo-, phyto …
Originally derived from the plant Cannabis sativa, there are now a number of endo-, phyto …
The current state and future perspectives of cannabinoids in cancer biology
P Śledziński, J Zeyland, R Słomski… - Cancer medicine, 2018 - Wiley Online Library
To date, cannabinoids have been allowed in the palliative medicine due to their analgesic
and antiemetic effects, but increasing number of preclinical studies indicates their anticancer …
and antiemetic effects, but increasing number of preclinical studies indicates their anticancer …
[HTML][HTML] Cannabinoids as therapeutic agents in cancer: current status and future implications
B Chakravarti, J Ravi, RK Ganju - Oncotarget, 2014 - ncbi.nlm.nih.gov
The pharmacological importance of cannabinoids has been in study for several years.
Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant,(b) …
Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant,(b) …